Cargando…

Unraveling the glycosylated immunopeptidome with HLA-Glyco

Recent interest in targeted therapies has been sparked by the study of MHC-associated peptides (MAPs) that undergo post-translational modifications (PTMs), particularly glycosylation. In this study, we introduce a fast computational workflow that merges the MSFragger-Glyco search algorithm with a fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedran, Georges, Polasky, Daniel A., Hsiao, Yi, Yu, Fengchao, da Veiga Leprevost, Felipe, Alfaro, Javier A., Cieslik, Marcin, Nesvizhskii, Alexey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258777/
https://www.ncbi.nlm.nih.gov/pubmed/37308510
http://dx.doi.org/10.1038/s41467-023-39270-2
_version_ 1785057537356201984
author Bedran, Georges
Polasky, Daniel A.
Hsiao, Yi
Yu, Fengchao
da Veiga Leprevost, Felipe
Alfaro, Javier A.
Cieslik, Marcin
Nesvizhskii, Alexey I.
author_facet Bedran, Georges
Polasky, Daniel A.
Hsiao, Yi
Yu, Fengchao
da Veiga Leprevost, Felipe
Alfaro, Javier A.
Cieslik, Marcin
Nesvizhskii, Alexey I.
author_sort Bedran, Georges
collection PubMed
description Recent interest in targeted therapies has been sparked by the study of MHC-associated peptides (MAPs) that undergo post-translational modifications (PTMs), particularly glycosylation. In this study, we introduce a fast computational workflow that merges the MSFragger-Glyco search algorithm with a false discovery rate control for glycopeptide analysis from mass spectrometry-based immunopeptidome data. By analyzing eight large-scale publicly available studies, we find that glycosylated MAPs are predominantly presented by MHC class II. Here, we present HLA-Glyco, a comprehensive resource containing over 3,400 human leukocyte antigen (HLA) class II N-glycopeptides from 1,049 distinct protein glycosylation sites. This resource provides valuable insights, including high levels of truncated glycans, conserved HLA-binding cores, and differences in glycosylation positional specificity between HLA allele groups. We integrate the workflow within the FragPipe computational platform and provide HLA-Glyco as a free web resource. Overall, our work provides a valuable tool and resource to aid the nascent field of glyco-immunopeptidomics.
format Online
Article
Text
id pubmed-10258777
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102587772023-06-14 Unraveling the glycosylated immunopeptidome with HLA-Glyco Bedran, Georges Polasky, Daniel A. Hsiao, Yi Yu, Fengchao da Veiga Leprevost, Felipe Alfaro, Javier A. Cieslik, Marcin Nesvizhskii, Alexey I. Nat Commun Article Recent interest in targeted therapies has been sparked by the study of MHC-associated peptides (MAPs) that undergo post-translational modifications (PTMs), particularly glycosylation. In this study, we introduce a fast computational workflow that merges the MSFragger-Glyco search algorithm with a false discovery rate control for glycopeptide analysis from mass spectrometry-based immunopeptidome data. By analyzing eight large-scale publicly available studies, we find that glycosylated MAPs are predominantly presented by MHC class II. Here, we present HLA-Glyco, a comprehensive resource containing over 3,400 human leukocyte antigen (HLA) class II N-glycopeptides from 1,049 distinct protein glycosylation sites. This resource provides valuable insights, including high levels of truncated glycans, conserved HLA-binding cores, and differences in glycosylation positional specificity between HLA allele groups. We integrate the workflow within the FragPipe computational platform and provide HLA-Glyco as a free web resource. Overall, our work provides a valuable tool and resource to aid the nascent field of glyco-immunopeptidomics. Nature Publishing Group UK 2023-06-12 /pmc/articles/PMC10258777/ /pubmed/37308510 http://dx.doi.org/10.1038/s41467-023-39270-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bedran, Georges
Polasky, Daniel A.
Hsiao, Yi
Yu, Fengchao
da Veiga Leprevost, Felipe
Alfaro, Javier A.
Cieslik, Marcin
Nesvizhskii, Alexey I.
Unraveling the glycosylated immunopeptidome with HLA-Glyco
title Unraveling the glycosylated immunopeptidome with HLA-Glyco
title_full Unraveling the glycosylated immunopeptidome with HLA-Glyco
title_fullStr Unraveling the glycosylated immunopeptidome with HLA-Glyco
title_full_unstemmed Unraveling the glycosylated immunopeptidome with HLA-Glyco
title_short Unraveling the glycosylated immunopeptidome with HLA-Glyco
title_sort unraveling the glycosylated immunopeptidome with hla-glyco
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258777/
https://www.ncbi.nlm.nih.gov/pubmed/37308510
http://dx.doi.org/10.1038/s41467-023-39270-2
work_keys_str_mv AT bedrangeorges unravelingtheglycosylatedimmunopeptidomewithhlaglyco
AT polaskydaniela unravelingtheglycosylatedimmunopeptidomewithhlaglyco
AT hsiaoyi unravelingtheglycosylatedimmunopeptidomewithhlaglyco
AT yufengchao unravelingtheglycosylatedimmunopeptidomewithhlaglyco
AT daveigaleprevostfelipe unravelingtheglycosylatedimmunopeptidomewithhlaglyco
AT alfarojaviera unravelingtheglycosylatedimmunopeptidomewithhlaglyco
AT cieslikmarcin unravelingtheglycosylatedimmunopeptidomewithhlaglyco
AT nesvizhskiialexeyi unravelingtheglycosylatedimmunopeptidomewithhlaglyco